Combined Inhibition of MEK and mTOR Signaling Inhibits Initiation and Progression of Colorectal Cancer

By Zhang Yan-Jie   Tian Xiao-Qing   Sun Dan-Feng   Zhao Shu-Liang   Xiong Hua   Fang Jing-Yuan  

Cancer Investigation, Vol. 27, Iss. 3, 2009-03 ,pp. : 273-285

Informa Healthcare

Access to resources Recommend Favorite

Combined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells

By Mise Josko  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 645-656

Springer Publishing Company

Access to resources Recommend Favorite

Ligustrazine Suppresses the Growth of HRPC Cells through the Inhibition of Cap- Dependent Translation Via Both the mTOR and the MEK/ERK Pathways

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 6, 2015-07 ,pp. : 764-772

Bentham Science Publishers

Access to resources Recommend Favorite

Patient-derived xenografts reveal limits to PI3K/mTOR- and MEK-mediated inhibition of bladder cancer

By Cirone Pasquale   Andresen Catharine   Eswaraka Jeetendra   Lappin Patrick   Bagi Cedo  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 525-538

Springer Publishing Company

Access to resources Recommend Favorite

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds

By Huang Yu   Chen Yu   Mei Qin   Chen Yuan   Yu Shiying   Xia Shu  

Oncology Reports, Vol. 29, Iss. 6, 2013-06 ,pp. : 2486-2492

Spandidos Publications

Access to resources Recommend Favorite